A pilot phase II open-label study of oglufanide disodium in patients with chronic hepatitis C

Trial Profile

A pilot phase II open-label study of oglufanide disodium in patients with chronic hepatitis C

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Oglufanide (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Sponsors Implicit Bioscience
  • Most Recent Events

    • 27 Jan 2009 Identified and integrated new information source (Australian Clinical Trials Registry record).
    • 27 Jan 2009 Status changed from recruiting to completed, according to the Australian New Zealand Clinical Trials Registry.
    • 06 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top